194 related articles for article (PubMed ID: 21808238)
1. Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice.
Wu J; Guan TJ; Zheng S; Grosjean F; Liu W; Xiong H; Gordon R; Vlassara H; Striker GE; Zheng F
Lab Invest; 2011 Oct; 91(10):1459-71. PubMed ID: 21808238
[TBL] [Abstract][Full Text] [Related]
2. Pentosan polysulfate exerts anti-inflammatory effect and halts albuminuria progression in diabetic nephropathy: Role of combined losartan.
Eita MAH; Ashour RH; El-Khawaga OY
Fundam Clin Pharmacol; 2022 Oct; 36(5):801-810. PubMed ID: 35434832
[TBL] [Abstract][Full Text] [Related]
3. Pentosan polysulfate ameliorates apoptosis and inflammation by suppressing activation of the p38 MAPK pathway in high glucose‑treated HK‑2 cells.
Chen P; Yuan Y; Zhang T; Xu B; Gao Q; Guan T
Int J Mol Med; 2018 Feb; 41(2):908-914. PubMed ID: 29207166
[TBL] [Abstract][Full Text] [Related]
4. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
[TBL] [Abstract][Full Text] [Related]
5. Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p.
Xiao L; Chen A; Gao Q; Xu B; Guo X; Guan T
BMC Nephrol; 2022 Mar; 23(1):105. PubMed ID: 35291969
[TBL] [Abstract][Full Text] [Related]
6. [Pentosan polysulfate sodium prevents kidney morphological changes and albuminuria in rats with type 1 diabetes].
Mathison Natera Y; Finol HJ; Quero Z; González R; González J
Nefrologia; 2010; 30(6):639-45. PubMed ID: 21113213
[TBL] [Abstract][Full Text] [Related]
7. NF-κB Inhibitor Parthenolide Promotes Renal Tubules Albumin Uptake in Type 2 Diabetic Nephropathy.
Hao QF; Wang BB; Zhang W; Qiu W; Liu QL; Li XM
Chin Med Sci J; 2020 Mar; 35(1):31-42. PubMed ID: 32299536
[TBL] [Abstract][Full Text] [Related]
8. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
[TBL] [Abstract][Full Text] [Related]
9. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
10. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
[TBL] [Abstract][Full Text] [Related]
11. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
[TBL] [Abstract][Full Text] [Related]
12. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
13. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
Zhang H; Yang Y; Wang Y; Wang B; Li R
Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886
[TBL] [Abstract][Full Text] [Related]
14. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P
PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792
[TBL] [Abstract][Full Text] [Related]
16. Blockade of TGF-β-activated kinase 1 prevents advanced glycation end products-induced inflammatory response in macrophages.
Xu X; Qi X; Shao Y; Li Y; Fu X; Feng S; Wu Y
Cytokine; 2016 Feb; 78():62-8. PubMed ID: 26687627
[TBL] [Abstract][Full Text] [Related]
17. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
18. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
[No Abstract] [Full Text] [Related]
19. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
[TBL] [Abstract][Full Text] [Related]
20. miR-218 regulates diabetic nephropathy via targeting IKK-β and modulating NK-κB-mediated inflammation.
Li M; Guo Q; Cai H; Wang H; Ma Z; Zhang X
J Cell Physiol; 2020 Apr; 235(4):3362-3371. PubMed ID: 31549412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
